van HOOFT et al. Endoscopic treatment of benign anastomotic esophageal strictures with a biodegradable stent (ESBIO). Endoscopy. 2010. 42 (Suppl I) A64.
Abstract OP291

Background: Benign cervical anastomotic strictures are a cumbersome entity often requiring repetitive dilatations before a clinical acceptable steady state is achieved.

Objective: The aim of this prospective single center feasibility study was to investigate the safety and efficacy of a biodegradable uncovered expandable stent (SX-ELLA Biodegradable Esophageal Stent BD, ELLA-CS, Hradec Kralove, Czech Republic) for the treatment of anastomotic esophageal strictures. Ten patients with dysphagia grade =2 (ability to eat semisolids, to swallow liquids or having complete obstruction) due to benign anastomotic esophageal strictures who fulfilled the patient selection criteria were included.

Main Outcome Measures: The primary outcome measure was endoscopic re-intervention within 6 months after stent placement. Secondary outcome measures were: improvement of dysphagia score at 1 week, 3 and 6 months, failed disintegration, increasing pain scores (visual analogue scale, 10 being worst possible pain) and complications. Patients' dysphagia score was listed weekly for the first month and thereafter monthly; their pain score was noted at day 1, 2 and 7. At 3 months a follow-up gastro-duodenoscopy was performed to investigate on stent disintegration and esophageal stricture. The total follow-up is 6 months.

Results: Between January 2009 and February 2010, 10 patients (8 men, 2 women; mean age ±standard deviation (SD) 62.1±6.8 years) were included. Nine patients had undergone esophagectomy because of esophageal carcinoma, one patient because of a Boerhaave's syndrome. Thus far 6 patients completed 6 months and 4 patients completed 4 months of follow-up. The dysphagia score improved significantly (Wilcoxon signed ranks test; p < 0.001) when comparing the mean score prior to stenting with the score at 1 week, 3 and if yet available 6 months. In all patients the stent disintegrated but was still partially visible at the 3 months endoscopy. Two patients suffered from pain (7 out of 10) directly after stent placement, the pain subsided completely within 1 week. Two patients (20%) required re-intervention because of reobstruction due to hyperplasia occurring 4 months after stent placement. No serious adverse events occurred.

Conclusions: Placement of the SX-ELLA biodegradable esophageal stent in patients with dysphagia due to benign anastomotic esophageal strictures appears to be safe and effective.
Chcete stránku vytisknout?
Skrýt před tiskem nějaké části stránky.
Vytisknout celou stránku tak, jak ji vidíte.
(tento box nebude vytištěn)
Úprava stránky před tiskem
Najeďte myší na nějaký obsah na stránce, zobrazí se červený obdélník. Kliknutím na něj obsah skryjete. Poté stiskněte tlačítko 'Vytisknout'.